iCAD Introduces PowerLook(TM) for its SecondLook(R) CAD Viewers
2005年10月25日 - 1:30AM
PRニュース・ワイアー (英語)
-- New CAD Viewer Provides Digital Viewing Support to Film Based
Mammography -- NASHUA, N.H., Oct. 24 /PRNewswire-FirstCall/ --
iCAD(R), Inc. (NASDAQ: ICAD), an industry-leading provider of
Computer-Aided Detection (CAD) solutions, today announced
PowerLook, a software extension to its SecondLook Viewer product
line. SecondLook Viewers are used in conjunction with the company's
SecondLook 300 and SecondLook 700 CAD Solutions. The SecondLook
Viewer displays a digital rendering of the mammogram, including CAD
marks to highlight suspicious areas on a mammogram, on a high
resolution, touch screen monitor. The iCAD system and the new
PowerLook viewer are designed and provided to support a radiologist
doing primary reading of mammograms and related diagnosis from the
original mammography films. PowerLook brings the essential tools of
digital reading to film based mammography, allowing a radiologist
to better understand the context in which a mammogram is marked
with CAD indicators, or in which an area that the radiologist
considers suspicious on primary reading is not marked by CAD
analysis. PowerLook offers: * Window / Level adjustment for
brightness control * Min / Max automatically adjusts the gray
levels to match the brightest and darkest areas in each mammogram *
Digital Zoom magnifies any portion of the digitized image up to 8
times * Pan allows the physician to easily move through the
enlarged portions of the image * Flip switches the orientation of
the image in the blink of an eye * Invert switches light for dark
and dark for light to invert the color scale * Rules or grids place
ruler tic marks or a full grid over the image so that measurements
converted to actual mm or inch units can be obtained * Print prints
the exact image adjustment made on each mammogram to paper or
Postscript file All of these PowerLook tools are used by merely
touching the screen. PowerLook creates a magnified portion of the
mammogram shown in reference to the full scale digitized image of
each view. The magnified image chip can be shown at 1X, 2X, 4X or
8x magnification. Window and Level can be operated in a continuous
motion or through 4 customized settings. The rules and grid
markings make measurement a breeze. The CAD markings are always
displayed with these Power tools. The recent Digital Mammography
Imaging Screening Test (DMIST) study released in September
highlights the comparative benefits of film-based and digital
mammography. Some of the digital benefits are made possible by
being able to read the case in a digital workflow. Digital Zoom,
rules, and window / level adjustments are far easier to use than
the traditional magnifying glass, clear plastic ruler, and bright
light. When offered for use with film based CAD, physicians can use
the new PowerLook features to further examine the information in
the image before making the final read based on the film. "The
workflow associated with softcopy reading has been shown to greatly
improve mammography reading. Our PowerLook viewer makes some of
these features accessible within the framework of film based
mammography. We believe that coupling PowerLook with our Gateway to
Digital Program makes the decision by film based mammography
centers to invest in CAD now, much easier," notes W. Scott Parr,
President and CEO of iCAD, Inc., "The costs of delaying a decision
to acquire CAD until moving to digital mammography are
significant," noted W. Scott Parr, President and CEO of iCAD, Inc.,
"in both clinical and economic terms." About iCAD, Inc. iCAD, Inc.
is an industry-leading provider of Computer-Aided Detection (CAD)
solutions that enable healthcare professionals to identify cancer
and other life-threatening conditions earlier by making medical
services more effective, more accessible and more affordable for
patients worldwide. Recipient of Frost & Sullivan's Growth
Strategy Leadership award, iCAD offers a comprehensive range of
high-performance, upgradeable CAD systems for the high, mid and low
volume mammography markets. iCAD is entrusted with the task of
early cancer detection by over eleven hundred women's healthcare
centers worldwide. For more information, call +1 877 iCADnow or
visit http://www.icadmed.com/. "Safe Harbor" Statement under the
Private Securities Litigation Reform Act of 1995: Certain
statements contained in this News Release constitute "forward-
looking statements" within the meaning of the Private Securities
Litigation Reform Act of 1995. Such forward-looking statements
involve a number of known and unknown risks, uncertainties and
other factors which may cause the actual results, performance or
achievements of the Company to be materially different from any
future results, performance or achievements expressed or implied by
such forward-looking statements. Such factors include, but are not
limited to, the risks of uncertainty of patent protection, the
impact of supply and manufacturing constraints or difficulties,
product market acceptance, possible technological obsolescence,
increased competition, customer concentration and other risks
detailed in the Company's filings with the Securities and Exchange
Commission. The words "believe," "demonstrate," "intend," "expect,"
"estimate," "anticipate," "likely," and similar expressions
identify forward- looking statements. Readers are cautioned not to
place undue reliance on those forward-looking statements, which
speak only as of the date the statement was made. The Company is
under no obligation to provide any updates to any information
contained in this release. iCAD and SecondLook are registered
trademarks and TotalLook is a trademark of iCAD, Inc. For iCAD
investor relations, contact Kevin McGrath of Cameron Associates at
+1 212 245 4577 or via email at . For all other inquires, contact
Monica Pandolfi of SHIFT Communications at +1 617 681 1235 or via
email at . DATASOURCE: iCAD, Inc. CONTACT: Kevin McGrath of Cameron
Associates for iCAD, +1-212-245-4577, .; or Monica Pandolfi of
SHIFT Communications, +1-617- 681-1235, Web site:
http://www.icadmed.com/
Copyright